Thursday, March 23, 2017
 
 
Company News: Page (1) of 1 - 03/16/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Champions Oncology Announces Plan to Open New Lab Facility in Rockville, Maryland
 
(March 16, 2017)

HACKENSACK, N.J., March 16, 2017 /PRNewswire/ -- Champions Oncology, Inc. (NASDAQ: CSBR), a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced plans for opening a new lab facility in Rockville, Maryland during the second quarter of its 2018 fiscal year. At current levels of business, the Company expects to realize a 10% reduction in lab costs.

Dr. Ronnie Morris, CEO stated, "Investment in this new lab facility represents an important strategic opportunity that will allow us to work more efficiently, provide space to further grow our business and enable significant cost saving opportunities. The opening of this facility will add to our capacity to grow the depth and breadth of our TumorBank and expand our pre-clinical and clinical drug development research. In line with our focus on operational excellence, in this new lab, we will have complete discretion to manage and operate the facility, including husbandry, to best support our business." 

The new facility will include office, conference, lab and vivarium space. The vivarium space will be nearly double the current capacity. 


About Champions Oncology

Champions Oncology, Inc. is engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs. The company's technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune-deficient mice to create TumorGrafts that preserve the biological characteristics of the original human tumor in order to determine the efficacy of a treatment regimen. The company uses this technology in conjunction with related services to offer solutions for two customer groups: Personalized Oncology Solutions, in which results help guide the development of personalized treatment plans, and Translational Oncology Solutions, in which pharmaceutical and biotechnology companies seeking personalized approaches to drug development can lower the cost and increase the speed of developing new drugs. For more information, please visit www.championsoncology.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/champions-oncology-announces-plan-to-open-new-lab-facility-in-rockville-maryland-300424511.html

SOURCE Champions Oncology, Inc.

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords: Inc., Science, Lifestyle, Medical, Cancer, Business,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • David A. Halsey MD, named first vice president of the American Academy of Orthopaedic Surgeons
  • Cryotherapy and Cryosurgery Market Rises High Incidence Of Cancer - IndustryARC
  • Global Radiology Oncology Surgical Robot Device Markets at $4 billion in 2015 are anticipated to reach $7.3 billion by 2022 - Acute Market Reports
  • FDA Approves Xadago® (Safinamide) for Parkinsons Disease (PD) Patients
  • Genomics Market Being Viewed As The Key To Achieving Human Immortality - IndustryARC Research

    Cancer
  • MOLOGEN AG: New strategic orientation, successful capital measures and notable study progress in 2016
  • FREEMAXDESK Brings In BEST Power Adjustable Desk Converter At Rates To Fit Pockets
  • Global Automotive Ceramics Market Size, Share, Growth Rate and Forecast by 2022 - Market Research Report 2017
  • Marcus Theatres® To Host Inaugural CineLatino Milwaukee Film Festival At South Shore Cinema, April 27-30
  • FACIT Announces Investment in Propellon Therapeutics
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines